research Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.






Incomplete name
Cedar Park, TX, United States
Düsseldorf, Nordrhein Westfalen, Germany
Jakarta, Indonesia
Savannah, GA, United States
Barcelona, Catalunya, Spain
Antibes, France